The Effect of Home-based Rehabilitation Program After COVID-19 Infection
NCT ID: NCT05317975
Last Updated: 2025-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
13 participants
INTERVENTIONAL
2021-07-15
2025-02-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiopulmonary Rehabilitation in Post-acute COVID-19 Syndrome
NCT05539950
Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation
NCT04695301
Aerobic Training for Rehabilitation of Patients With Post Covid-19 Syndrome
NCT06016192
3R Rehabilitation Management of COVID-19 Survivors
NCT04892979
Effects of Cardiac Telerehabilitation During COVID-19 on Cardiorespiratory Capacities in Coronary Artery Disease Patients.
NCT05749744
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Add-on telerehabilitation combined with usual home-based rehabilitation
Add-on telerehabilitation combined with usual home-based rehabilitation
Add-on telerehabilitation and home-based rehabilitation
1. 12wk home-based rehabilitation including individualized exercise training and inspiratory muscle training with symptoms monitoring. Participants will be provided with a manual and routine telephone follow-up by a case manager.
2. Add-on telerehabilitation for instruction and supervision of exercise training
Stand-alone usual home-based rehabilitation
Stand-alone usual home-based rehabilitation
Home-based rehabilitation alone
12wk home-based rehabilitation including individualized exercise training and inspiratory muscle training with symptoms monitoring. Participants will be provided with a manual and routine telephone follow-up by a case manager.
Usual care
Usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Add-on telerehabilitation and home-based rehabilitation
1. 12wk home-based rehabilitation including individualized exercise training and inspiratory muscle training with symptoms monitoring. Participants will be provided with a manual and routine telephone follow-up by a case manager.
2. Add-on telerehabilitation for instruction and supervision of exercise training
Home-based rehabilitation alone
12wk home-based rehabilitation including individualized exercise training and inspiratory muscle training with symptoms monitoring. Participants will be provided with a manual and routine telephone follow-up by a case manager.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. COVID-19 survivor after de-isolation at post-acute stage about to be discharged or already at outpatient follow-up who still have symptoms or exercise intolerance.
Exclusion Criteria
2. Dependent in basic activities of living before infection (Premorbid Barthel index \<80).
3. End stage patient, with life expectancy less than 1 year.
4. Having contraindications for exercise according to the evaluation of a physician.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hung-Jui Chuang, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202106093RIND
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.